Your Health, We Care
The most common (≥ 20%) adverse reactions are:
1.As a single agent: diarrhea, fatigue, PPE, decreased appetite, hypertension, nausea, vomiting, weight decreased, constipation.
2.In combination with nivolumab: diarrhea, fatigue, hepatotoxicity, PPE, stomatitis, rash, hypertension, hypothyroidism, musculoskeletal pain, decreased appetite, nausea, dysgeusia, abdominal pain, cough, and upper respiratory tract infection.
from FDA，2023.09
Scan code
Whatsapp
Cabozantinib is a widely used drug for the treatment of a variety of cancers, and its side effects are of great concern.Does cabozantinib have side effectsExploring the side effect···【more】
Article source：Lucius LaosRelease date：2025-02-21Recommended：86
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has demonstrated significant efficacy in a variety of cancer treatments. However, its accompanying side effects have···【more】
Article source：Lucius LaosRelease date：2025-02-21Recommended：111
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has shown significant efficacy in the treatment of a variety of cancers, but its accompanying side effects are also ···【more】
Article source：Lucius LaosRelease date：2025-02-20Recommended：93
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
